Episode 71: Weight-loss drug stocks

As obesity impacts more than 1 billion people globally, including 40% of Americans and 30% of Canadians, weight-loss drugs are creating significant opportunities for investors in publicly traded pharmaceutical companies. This week, we look at two profiles worth your attention: Viking Therapeutics Inc. (NASDAQ:GPCR) and Structure Therapeutics Inc. (NASDAQ:VKTX). Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.